Table 4.
No. of patients | Odds ratio | 95% CI | p value* | |
---|---|---|---|---|
miTNM classification, no., n = 186 | ||||
miT status | ||||
2 | 125 | Reference | ||
≥ 3a | 61 | 2.065 | 0.802–5.315 | 0.133 |
miN status | ||||
No LN metastasis | 168 | Reference | ||
With LN metastasis | 18 | 5.428 | 1.708–17.249 | 0.004 |
SUVmax of prostatic lesions | 183 | 1.015 | 0.988–1.044 | 0.282 |
TL of prostatic lesions | 183 | 1.004 | 0.998–1.011 | 0.166 |
CI confidence interval, LN lymph node, PET positron emission tomography, PSMA prostate-specific membrane antigen, SUV standardized uptake value, TL total lesion, TV tumor volume
*Significant associations are given in bold